Monopar Therapeutics Quarterly Entity Common Stock, Shares Outstanding from Q1 2018 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Monopar Therapeutics quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2018 to Q3 2024.
  • Monopar Therapeutics Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 5.28M shares, a 64.5% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 5.28M -9.59M -64.5% Oct 31, 2024 10-Q 2024-11-08
Q2 2024 17.6M +3.44M +24.3% Jul 31, 2024 10-Q 2024-08-09
Q1 2024 17.5M +4.26M +32.3% Mar 8, 2024 10-K 2024-03-28
Q3 2023 14.9M +2.01M +15.6% Nov 7, 2023 10-Q 2023-11-09
Q2 2023 14.2M +1.43M +11.3% Jul 28, 2023 10-Q 2023-08-10
Q1 2023 13.2M +589K +4.67% Mar 10, 2023 10-K 2023-03-23
Q3 2022 12.9M +265K +2.11% Oct 31, 2022 10-Q 2022-11-10
Q2 2022 12.7M +143K +1.14% Jul 29, 2022 10-Q 2022-08-11
Q1 2022 12.6M +37.6K +0.3% Mar 11, 2022 10-K 2022-03-24
Q3 2021 12.6M +1.14M +9.94% Oct 31, 2021 10-Q 2021-11-12
Q2 2021 12.6M +1.85M +17.2% Jul 31, 2021 10-Q 2021-08-12
Q1 2021 12.6M +1.95M +18.3% Mar 5, 2021 10-K 2021-03-25
Q3 2020 11.5M +2.16M +23.3% Oct 31, 2020 10-Q 2020-11-12
Q2 2020 10.7M +1.44M +15.6% Jul 31, 2020 10-Q 2020-08-06
Q1 2020 10.6M +1.33M +14.3% Mar 13, 2020 10-K 2020-03-27
Q3 2019 9.29M -0.39 0% Nov 12, 2019 10-Q 2019-11-12
Q2 2019 9.29M 0 0% Aug 9, 2019 10-Q 2019-08-08
Q1 2019 9.29M -0.39 0% Feb 25, 2019 10-K 2019-02-26
Q3 2018 9.29M Nov 9, 2018 10-Q 2018-11-09
Q2 2018 9.29M Aug 9, 2018 10-Q 2018-08-09
Q1 2018 9.29M Mar 26, 2018 10-K 2018-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.